US 2006/0217292 A1Published application

Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals

OwnerThomas Harrisinventor

Life of this patent

Estimating the term…

Abstract

The present invention is directed to a compound comprising a thiol derivatized targeting moiety. The targeting moiety binds to a receptor which his upregulated during angiogenesis.

Claims20

Dependent claims

A compound, comprising a thiol derivatized targeting moiety that binds to a receptor that is upregulated during angiogenesis.

Dependencies are inferred from the claim text.

Facts

Application: 10/555,804Filed 12 May 2004
Priority: 12 May 2003
Published: 28 Sep 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification3 codes

A61K 49/223
Characterised by a special physical form, e.g. emulsions, liposomes: microbubbles, hollow microspheres, free gas bubbles, gas microspheres
A61K 47/545
The modifying agent being an organic compound: heterocyclic compounds
A61K
Medicines and medical preparations

Family

Application60/469,728Us provisional application · filed 12 May 2003
Application10/842,862Continuation · filed 11 May 2004
Application10/555,804Continuation · filed 3 Nov 2005
US 2006/0217292 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results